Northwest Biotherapeutics, Inc.
OTC: NWBO0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Linda F. Powers
- Employees
- 25
- Headquarters
- Bethesda, United States
- IPO year
- 2001
- Market cap
- $310.8M
- Website
- https://www.nwbio.com
Loading NWBO…
Loading profile data…Frequently asked questions about NWBO
What does Northwest Biotherapeutics, Inc. (NWBO) do?
Northwest Biotherapeutics, Inc. (NWBO) is a biotechnology firm that creates personalized immune-based treatments for various cancers, operating both within the United States and internationally. Their product pipeline relies on DCVax, a proprietary technology platform. This platform harnesses a patient's own activated dendritic cells to stimulat...
Where does NWBO trade?
Northwest Biotherapeutics, Inc. (NWBO) trades on the Other OTC.
What sector is NWBO in?
Northwest Biotherapeutics, Inc. (NWBO) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Northwest Biotherapeutics, Inc.?
Linda F. Powers is the chief executive officer of Northwest Biotherapeutics, Inc. (NWBO).
Where is Northwest Biotherapeutics, Inc. headquartered?
Northwest Biotherapeutics, Inc. is headquartered in United States.
Does NWBO pay a dividend?
Northwest Biotherapeutics, Inc. (NWBO) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did NWBO go public?
Northwest Biotherapeutics, Inc. (NWBO) completed its initial public offering in 2001.